Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 16,000 shares at $79.14 ($1.3M) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Scheduled sale ($1.3M) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.25 | 4,994 | $391K | 31.1% |
| 2 | $78.25 | 4,994 | $391K | 31.1% |
| 3 | $79.14 | 3,006 | $238K | 18.9% |
| 4 | $79.14 | 3,006 | $238K | 18.9% |
| Total | $78.58 avg | 16,000 | $1.3M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |